Fig. 1
From: SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia
Identification of SLCs expression associated with prognosis in AML by public database. A–E SLC5A8, SLC6A11, SLC7A14, SLC22A3, SLC34A2. The impact of SLCs expression on OS and DFS was detected among non-APL AML and CN-AML patients from TCGA databases. AML patients were divided into two groups by the median mRNA expression level of each gene, respectively. F Correlation between DNA methylation and mRNA expression of SLC22A3 in AML from TCGA database. G The impact of SLC22A3 expression on OS was detected among total-cohort AML and CN-AML patients from beat AML database. AML patients were divided into two groups by the median SLC22A3 expression level